Grant: Team Grant: E-Rare Joint Transnational Call
McMaster University
$284,728.00
The psychosocial, economic, and patient-reported impact of Friedreich's Ataxia
FY 2021-22
Summary
Friedreich's ataxia (FRDA) is the most common hereditary ataxia in Europe characterized by imbalance, poor coordination, speech problems, muscle weakness, sensory loss, cardiomyopathy, skeletal abnormalities, and diabetes mellitus with typical onset before the age of 25 years. FRDA is associated with impaired health-related quality of life, reduced social inclusion, and an increasing need for care, resulting in a psychosocial and economic burden. Therefore, in the light of new therapeutic interventions, we aim to assess patient-reported outcomes, specifically including dysarthria, as well as the health economic impact of FRDA. Data will be acquired in real-time in members of a large prospective clinical cohort of FRDA patients (European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort by using a patient-centric, remote monitoring e-health app. Within the e-health app, ataxia severity, daily activity, health-related quality of life (patient-reported outcomes), medication and health services used (health economic outcomes), and specific events that affect patients' health will be monitored in real-time on a daily to monthly basis. We will assess (1) the acceptability, feasibility, and usability of the app, (2) the total societal costs (medical care cost and indirect costs, including productivity losses and cost of informal care) as well as the association between treatment patterns that adhere to evidence-based guidelines and costs, (3) the health-related quality of life in FRDA, its associated factors and the fluctuation of health as well as (4) the psychosocial impact of the communication handicap caused by dysarthria.
Department
Program
Team Grant: E-Rare Joint Transnational Call
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
450123
Name
Xie Feng
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
German Federal Ministry of Research, Technology and Space (Berlin); The French National Research Agency (France)
Instname2
Health Services and Policy Research
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Special Cases
Projecttitle
The psychosocial, economic, and patient-reported impact of Friedreich's Ataxia
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$284,728
Cihrequipment2
$0
Programname2
Team Grant: E-Rare Joint Transnational Call
Keyworddelim
Economic Burden; Friedreich'S Ataxia; Health-Related Quality Of Life; Paediatric Rare Disease; Patient-Reported Outcomes; Psychosocial Impact
Abstract
Friedreich's ataxia (FRDA) is the most common hereditary ataxia in Europe characterized by imbalance, poor coordination, speech problems, muscle weakness, sensory loss, cardiomyopathy, skeletal abnormalities, and diabetes mellitus with typical onset before the age of 25 years. FRDA is associated with impaired health-related quality of life, reduced social inclusion, and an increasing need for care, resulting in a psychosocial and economic burden. Therefore, in the light of new therapeutic interventions, we aim to assess patient-reported outcomes, specifically including dysarthria, as well as the health economic impact of FRDA. Data will be acquired in real-time in members of a large prospective clinical cohort of FRDA patients (European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort by using a patient-centric, remote monitoring e-health app. Within the e-health app, ataxia severity, daily activity, health-related quality of life (patient-reported outcomes), medication and health services used (health economic outcomes), and specific events that affect patients' health will be monitored in real-time on a daily to monthly basis. We will assess (1) the acceptability, feasibility, and usability of the app, (2) the total societal costs (medical care cost and indirect costs, including productivity losses and cost of informal care) as well as the association between treatment patterns that adhere to evidence-based guidelines and costs, (3) the health-related quality of life in FRDA, its associated factors and the fluctuation of health as well as (4) the psychosocial impact of the communication handicap caused by dysarthria.
Competitiondate
202106
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Xie, Feng
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Genetics~ $284,728~ $0~